Hybrid PET/MRI for in Vivo imaging of cancer: Current clinical experiences and recent advances

Isabella Castiglioni, Francesca Gallivanone, Carla Canevari

Research output: Contribution to journalArticle

Abstract

Hybrid PET/MRI represents an innovative diagnostic technology for non-invasive in vivo imaging of cancer. Although the current clinical experience is limited to few clinical centres investing in such an ambitious technology, preliminary results are showing potentials for hybrid PET/MRI to enter in the clinical setting as imaging technology that can profoundly impact on the pool of available in vivo multimodal imaging studies. The higher contrast increases detectability of oncological lesions in specific applications; the reduction of radiation exposure leads benefits for children and young adults and for follow-up studies; the multi-functionality of PET/MRI opens up to several opportunities for assessing cancer disease and for addressing oncological patients to optimal care.

Original languageEnglish
Pages (from-to)106-117
Number of pages12
JournalCurrent Hypertension Reviews
Volume12
Issue number2
Publication statusPublished - May 1 2016
Externally publishedYes

Fingerprint

Technology
Multimodal Imaging
Neoplasms
Young Adult
Radiation Exposure

Keywords

  • Clinical PET/MRI
  • Hybrid imaging
  • MRI nanotechnology application
  • Multi-parametric MRI
  • Oncology
  • PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Hybrid PET/MRI for in Vivo imaging of cancer : Current clinical experiences and recent advances. / Castiglioni, Isabella; Gallivanone, Francesca; Canevari, Carla.

In: Current Hypertension Reviews, Vol. 12, No. 2, 01.05.2016, p. 106-117.

Research output: Contribution to journalArticle

Castiglioni, I, Gallivanone, F & Canevari, C 2016, 'Hybrid PET/MRI for in Vivo imaging of cancer: Current clinical experiences and recent advances', Current Hypertension Reviews, vol. 12, no. 2, pp. 106-117.
Castiglioni, Isabella ; Gallivanone, Francesca ; Canevari, Carla. / Hybrid PET/MRI for in Vivo imaging of cancer : Current clinical experiences and recent advances. In: Current Hypertension Reviews. 2016 ; Vol. 12, No. 2. pp. 106-117.
@article{60b0dbe08a444eeb9e3b3701139e97d4,
title = "Hybrid PET/MRI for in Vivo imaging of cancer: Current clinical experiences and recent advances",
abstract = "Hybrid PET/MRI represents an innovative diagnostic technology for non-invasive in vivo imaging of cancer. Although the current clinical experience is limited to few clinical centres investing in such an ambitious technology, preliminary results are showing potentials for hybrid PET/MRI to enter in the clinical setting as imaging technology that can profoundly impact on the pool of available in vivo multimodal imaging studies. The higher contrast increases detectability of oncological lesions in specific applications; the reduction of radiation exposure leads benefits for children and young adults and for follow-up studies; the multi-functionality of PET/MRI opens up to several opportunities for assessing cancer disease and for addressing oncological patients to optimal care.",
keywords = "Clinical PET/MRI, Hybrid imaging, MRI nanotechnology application, Multi-parametric MRI, Oncology, PET",
author = "Isabella Castiglioni and Francesca Gallivanone and Carla Canevari",
year = "2016",
month = "5",
day = "1",
language = "English",
volume = "12",
pages = "106--117",
journal = "Current Hypertension Reviews",
issn = "1573-4021",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Hybrid PET/MRI for in Vivo imaging of cancer

T2 - Current clinical experiences and recent advances

AU - Castiglioni, Isabella

AU - Gallivanone, Francesca

AU - Canevari, Carla

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Hybrid PET/MRI represents an innovative diagnostic technology for non-invasive in vivo imaging of cancer. Although the current clinical experience is limited to few clinical centres investing in such an ambitious technology, preliminary results are showing potentials for hybrid PET/MRI to enter in the clinical setting as imaging technology that can profoundly impact on the pool of available in vivo multimodal imaging studies. The higher contrast increases detectability of oncological lesions in specific applications; the reduction of radiation exposure leads benefits for children and young adults and for follow-up studies; the multi-functionality of PET/MRI opens up to several opportunities for assessing cancer disease and for addressing oncological patients to optimal care.

AB - Hybrid PET/MRI represents an innovative diagnostic technology for non-invasive in vivo imaging of cancer. Although the current clinical experience is limited to few clinical centres investing in such an ambitious technology, preliminary results are showing potentials for hybrid PET/MRI to enter in the clinical setting as imaging technology that can profoundly impact on the pool of available in vivo multimodal imaging studies. The higher contrast increases detectability of oncological lesions in specific applications; the reduction of radiation exposure leads benefits for children and young adults and for follow-up studies; the multi-functionality of PET/MRI opens up to several opportunities for assessing cancer disease and for addressing oncological patients to optimal care.

KW - Clinical PET/MRI

KW - Hybrid imaging

KW - MRI nanotechnology application

KW - Multi-parametric MRI

KW - Oncology

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=84961589869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961589869&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84961589869

VL - 12

SP - 106

EP - 117

JO - Current Hypertension Reviews

JF - Current Hypertension Reviews

SN - 1573-4021

IS - 2

ER -